NXTM - Nxstage Medical, Inc.

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue366,378336,123301,501
Cost of Revenue214,393204,652185,598
Gross Profit151,985131,471115,903
Operating Expenses
Research Development31,03226,23722,635
Selling General and Administrative125,238119,863115,455
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-4,285-14,629-22,187
Income from Continuing Operations
Total Other Income/Expenses Net-930561-10
Earnings Before Interest and Taxes-5,215-14,068-22,197
Interest Expense1,0001,115863
Income Before Tax-6,215-15,183-23,060
Income Tax Expense1,1021,0771,253
Minority Interest6251,6941,088
Net Income From Continuing Ops-4,771-15,342-23,946
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-4,771-15,342-23,946
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-4,771-15,342-23,946